SANUWAVE Health, Inc. current report, Q4 FY2018

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 15, 2018
Reporting Period: Third quarter ended September 30, 2018
Event: Announcement of product revenue and business update via conference call.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that the Company announced "strong third quarter revenue" and refers investors to attached exhibits for detailed figures.

Material Changes

The filing indicates a positive business update regarding product revenue for the three months ended September 30, 2018, described in the press release as "strong." No specific comparative data or percentage changes versus the prior period are included in the text of this Form 8-K.

Guidance, Outlook, and Risks

Management Commentary: The Company provided a business update via a conference call on November 15, 2018.
Exhibits:

  • Exhibit 99.1: Press release titled "SANUWAVE Health reports strong third quarter revenue."
  • Exhibit 99.2: Transcript of the November 15, 2018 conference call.
Legal Disclaimer: Information in Item 2.02 and the attached exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release) for the specific dollar amount of product revenue for the quarter ended September 30, 2018.
  • Consult Exhibit 99.2 (Conference Call Transcript) for detailed management commentary on the "strong" revenue performance and future outlook.
  • Verify if the "strong" revenue claim includes specific year-over-year or quarter-over-quarter growth percentages not listed in the main filing text.
  • Check subsequent filings for the full audited financial statements to confirm the revenue figures and assess overall financial health (cash flow, debt, margins).